HomeHeadlinesMerck's Keytruda Gets New FDA Approval For Expanded Use In Pretreated Ovarian Cancer PatientsFEBRUARY 11, 2026 AT 03:14 PMMerck's Keytruda Gets New FDA Approval For Expanded Use In Pretreated Ovarian Cancer PatientsByNewsquawk StaffSourceBenzinga NewsImportanceLevel 1Merck's Keytruda Gets New FDA Approval For Expanded Use In Pretreated Ovarian Cancer Patients#FDA#US EQUITIES
FEBRUARY 11, 2026 AT 03:14 PMMerck's Keytruda Gets New FDA Approval For Expanded Use In Pretreated Ovarian Cancer PatientsByNewsquawk StaffSourceBenzinga NewsImportanceLevel 1Merck's Keytruda Gets New FDA Approval For Expanded Use In Pretreated Ovarian Cancer Patients#FDA#US EQUITIES